1-9 of 9
Daniel Furst
Close
Sort by
Journal Articles

Unrelated Donors below 35 Years of Age Should be Preferred over HLA-Matched Sibling Donors Older Than 50 Years for Patients with Myeloid Malignancies

Johannes Schetelig, Henning Baldauf, Carina Rave, Gesine Bug, Lutz Peter Hermann Mueller, Eva Wagner Drouet, Francis A. Ayuk, Wolfgang Andreas Bethge, Matthias Stelljes, Thomas Schröder, Desiree Kunadt, Katja Sockel, Jan Moritz Middeke, Daniel Fürst, Alexander H. Schmidt, Katharina Fleischhauer, Martin Bornhäuser
Journal: Blood
Blood (2023) 142 (Supplement 1): 1046.
https://doi.org/10.1182/blood-2023-180531
Published: 2023
Journal Articles

Monitoring the in-Vivo Expansion and Persistence of CAR-T Cells As a Tool to Help Decision Making in Patients with Aggressive B-Cell Lymphoma

Daniel Fürst, Christine Neuchel, Adela Neagoie, Elisa Amann, Immanuel Rode, Angela Krauss, Hubert Schrezenmeier, Verena Wais, Hartmut Döhner, Andreas Viardot, Elisa Sala
Journal: Blood
Blood (2022) 140 (Supplement 1): 7527–7528.
https://doi.org/10.1182/blood-2022-169212
Published: 2022
Journal Articles

Donor Genetic Determinant of Thymopoiesis rs2204985 Impacts Clinical Outcome after Single HLA Mismatched HSCT

Chrysanthi Tsamadou, Sowmya Gowdavally, Uwe Platzbecker, Elisa Sala, Thomas Valerius, Gerald Wulf, Eva Maria Wagner, Nicolaus Kroeger, Niels Murawski, Hermann Einsele, Kerstin Schaefer-Eckart, Sebastian Freitag, Jochen Casper, Martin Kaufmann, Mareike Dürholt, Bernd Hertenstein, Stefan Klein, Mark Ringhoffer, Christine Neuchel, Immanuel Rode, Joannis Mytilineos, Hubert Schrezenmeier, Daniel Fürst
Journal: Blood
Blood (2021) 138 (Supplement 1): 3903.
https://doi.org/10.1182/blood-2021-144748
Published: 2021
Journal Articles

External validation of models for KIR2DS1/KIR3DL1-informed selection of hematopoietic cell donors fails

Clinical Trials & Observations
Johannes Schetelig, Henning Baldauf, Falk Heidenreich, Carolin Massalski, Sandra Frank, Jürgen Sauter, Matthias Stelljes, Francis Ayuketang Ayuk, Wolfgang A. Bethge, Gesine Bug, Stefan Klein, Sarah Wendler, Vinzenz Lange, Liesbeth C. de Wreede, Daniel Fürst, Guido Kobbe, Hellmut D. Ottinger, Dietrich W. Beelen, Joannis Mytilineos, Katharina Fleischhauer, Alexander H. Schmidt, Martin Bornhäuser
Journal: Blood
Blood (2020) 135 (16): 1386–1395.
https://doi.org/10.1182/blood.2019002887
Published: 2020
Includes: Supplemental data
Journal Articles

Classification of Donor KIR-Genotype Information to Predict Outcome after Unrelated Hematopoietic Stell Cell Transplantation: The Jury Is Still out

Johannes Schetelig, MDMSc, Henning Baldauf, Carolin Massalski, Sandra Frank, Jürgen Sauter, Matthias Stelljes, MD, Francis A. Ayuk, MD, Armin Gerbitz, MD, Wolfgang Bethge, MD, Gesine Bug, Stefan A Klein, MD, Sarah Wendler, MSc, Falk Heidenreich, Julia Luedemann, Vinzenz Lange, PhD, Liesbeth C. de Wreede, PhD, Daniel Fürst, MD PhD, Alexander H. Schmidt, Guido Kobbe, Hellmut Dietmar Ottinger, MD PhD, Carlheinz Mueller, Dietrich W. Beelen, Joannis Mytilineos, MD PhD, Katharina Fleischhauer, Martin Bornhäuser, MD
Journal: Blood
Blood (2018) 132 (Supplement 1): 2162.
https://doi.org/10.1182/blood-2018-99-111242
Published: 2018
Journal Articles

The Role of HLA-E Polymorphism in Acute Leukemia Patients Receiving a 10/10 HLA Matched Unrelated HSCT

Chrysanthi Tsamadou, MD, Tao Wang, PhD, Daniel Fürst, MD PhD, Stephanie J. Lee, MD MPH, Stephen R. Spellman, Katharina Fleischhauer, Katharine C. Hsu, MD PhD, Sophie Paczesny, MD PhD, Michael R Verneris, MD, Christine Neuchel, PhD, Hubert Schrezenmeier, MD, Joannis Mytilineos, MD PhD
Journal: Blood
Blood (2018) 132 (Supplement 1): 310.
https://doi.org/10.1182/blood-2018-99-113432
Published: 2018
Journal Articles

High-resolution HLA matching in hematopoietic stem cell transplantation: a retrospective collaborative analysis

Clinical Trials & Observations
Daniel Fürst, Carlheinz Müller, Vladan Vucinic, Donald Bunjes, Wolfgang Herr, Martin Gramatzki, Rainer Schwerdtfeger, Renate Arnold, Hermann Einsele, Gerald Wulf, Michael Pfreundschuh, Bertram Glass, Hubert Schrezenmeier, Klaus Schwarz, Joannis Mytilineos
Journal: Blood
Blood (2013) 122 (18): 3220–3229.
https://doi.org/10.1182/blood-2013-02-482547
Published: 2013
Journal Articles

Four-Year Follow-Up after High-Dose Immunosuppressive Therapy (HDIT) for Severe Systemic Sclerosis (SSc).

Richard A. Nash, Peter McSweeney, Leslie Crofford, Kevin T. McDonagh, Maureen Mayes, J. Lee Nelson, Ted Gooley, Leona Holmberg, Howard Shulman, Mark Wener, Bernadette McLaughlin, Gretchen Henstorf, Jerry Molitor, James Seibold, Keith Sullivan, Daniel Furst
Journal: Blood
Blood (2006) 108 (11): 3071.
https://doi.org/10.1182/blood.V108.11.3071.3071
Published: 2006
Journal Articles

High-Dose Immunosuppressive Therapy (HDIT) for Severe Systemic Sclerosis (SSc): Long-Term Survivors Show Continued Improvement of Function and Skin with Stability in the Lungs.

Peter McSweeney, MD, Daniel Furst, MD, Leslie Crofford, MD, Kevin McDonagh, MD, Keith Sullivan, MD, Mayes Maureen, MD, Nelson Lee, MD, Theodore Gooley, Ph.D., Jan Storek, MD, PhD, Leona Holmberg, MD, PhD, C.S. Chen, MD, PhD, Mark Wener, MD, Julie Lee, RN, Gretchen Henstorf, CCRC, Muneer Abidi, MD, Philip Mease, MD, Richard Nash, MD
Journal: Blood
Blood (2004) 104 (11): 149.
https://doi.org/10.1182/blood.V104.11.149.149
Published: 2004